Evidence map›Paper›PMID 38031187›Full record

ArticleGenome medicine2023

Evaluating the association of biallelic OGDHL variants with significant phenotypic heterogeneity.

Sheng-Jia Lin, Barbara Vona, Tracy Lau, Kevin Huang, Maha S Zaki, Huda Shujaa Aldeen, Ehsan Ghayoor Karimiani, Clarissa Rocca, Mahmoud M Noureldeen, Ahmed K Saad and 27 more

Open access · goldAbstract read
In one paragraph

Article in Genome medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

37 authors at 20 institutions in 8 countries.

Sheng-Jia Lin *Genes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA.
Barbara Vona *Institute of Human Genetics, Julius Maximilians University Würzburg, Würzburg, Germany.
Tracy LauDepartment of Neuromuscular Disorders, Queen Square Institute of Neurology, University College London, London, UK.
Kevin HuangGenes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA.
Maha S ZakiClinical Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
Huda Shujaa AldeenDepartment of Neuromuscular Disorders, Queen Square Institute of Neurology, University College London, London, UK.
Ehsan Ghayoor KarimianiMolecular and Clinical Sciences Institute, St. George's, University of London, Cranmer Terrace London, London, UK.
Clarissa RoccaDepartment of Neuromuscular Disorders, Queen Square Institute of Neurology, University College London, London, UK.
Mahmoud M NoureldeenDepartment of Pediatrics, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Ahmed K SaadMedical Molecular Genetics Department, Human Genetics and Genome Research Institute, National Research Centre, Cairo, Egypt.
Cassidy PetreeGenes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA.
Tobias BartolomaeusInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Rami Abou JamraInstitute of Human Genetics, University of Leipzig Medical Center, Leipzig, Germany.
Giovanni ZifarelliCentogene GmbH, Rostock, Germany.
Aditi GotkhindikarBioinformatics Centre, S. P. Pune University, Pune, India.
Ingrid M WentzensenGeneDx, Gaithersburg, MD, 20877, USA.
Mingjuan LiaoGeneDx, Gaithersburg, MD, 20877, USA.
Emalyn Elise CorkDepartment of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Pratishtha VarshneyGenes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA.
Narges HashemiDepartment of Pediatrics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Mohammad Hasan MohammadiDepartment of Pediatrics, Zabol University of Medical Sciences, Zabol, Iran.
Aboulfazl RadDepartment of Otolaryngology-Head and Neck Surgery, Tübingen Hearing Research Center, Eberhard Karls University, Tübingen, 72076, Germany.
Juanita NeiraDepartment of Human Genetics, Emory University, Atlanta, GA, 30322, USA.
Mehran Beiraghi ToosiDepartment of Pediatrics, School of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran.
Cordula KnoppInstitute for Human Genetics and Genomic Medicine, RWTH Aachen University, Pauwelsstr. 30, Aachen, 52074, Germany.
Ingo KurthInstitute for Human Genetics and Genomic Medicine, RWTH Aachen University, Pauwelsstr. 30, Aachen, 52074, Germany.
Thomas D ChallmanAutism & Developmental Medicine Institute, Geisinger, Lewisburg, PA, USA.
Rebecca SmithAutism & Developmental Medicine Institute, Geisinger, Lewisburg, PA, USA.
Asmahan AbdallaDepartment of Pediatric Endocrinology, Gaafar Ibn Auf Children's Tertiary Hospital, Khartoum, Sudan.
Thomas HaafInstitute of Human Genetics, Julius Maximilians University Würzburg, Würzburg, Germany.
Mohnish SuriNottingham Clinical Genetics Service, Nottingham University Hospitals NHS Trust, Nottingham, UK.
Manali JoshiBioinformatics Centre, S. P. Pune University, Pune, India.
Wendy K ChungDepartment of Pediatrics, Boston Children's Hospitaland, Harvard Medical School , Boston, MA, USA.
Andres Moreno-De-LucaDepartment of Diagnostic Radiology, Kingston Health Sciences Centre, Queen's University, Kingston, ON, Canada.
Henry HouldenDepartment of Neuromuscular Disorders, Queen Square Institute of Neurology, University College London, London, UK.
Reza MaroofianDepartment of Neuromuscular Disorders, Queen Square Institute of Neurology, University College London, London, UK. r.maroofian@ucl.ac.uk.
Gaurav K VarshneyGenes & Human Disease Research Program, Oklahoma Medical Research Foundation, Oklahoma City, OK, 73104, USA. gaurav-varshney@omrf.org.ORCID 0000-0002-0429-1904
Oklahoma Medical Research Foundation · USNational Hospital for Neurology and Neurosurgery · GBAutism & Developmental Medicine Institute · USLeipzig University · DEMashhad University of Medical Sciences · IRNational Research Centre · EGRWTH Aachen University · DESavitribai Phule Pune University · INUniversity of Würzburg · DEBeni-Suef University · EGBoston Children's Hospital · USCentogene (Germany) · DEEmory University · USIcahn School of Medicine at Mount Sinai · USNottingham University Hospitals NHS Trust · GBQueen Mary University of London · GBQueen's University · CASt George's, University of London · GBSudan Medical Specialization Board · SDUniversity of Tübingen · DE

Funding

Medical Research Council MR/S005021/1Medical Research Council MR/S01165X/1Wellcome TrustWellcome Trust 221951/Z/20/Z
6 · The paper itself

Abstract

backgroundBiallelic variants in OGDHL, encoding part of the α-ketoglutarate dehydrogenase complex, have been associated with highly heterogeneous neurological and neurodevelopmental disorders. However, the validity of this association remains to be confirmed. A second OGDHL patient cohort was recruited to carefully assess the gene-disease relationship.

methodsUsing an unbiased genotype-first approach, we screened large, multiethnic aggregated sequencing datasets worldwide for biallelic OGDHL variants. We used CRISPR/Cas9 to generate zebrafish knockouts of ogdhl, ogdh paralogs, and dhtkd1 to investigate functional relationships and impact during development. Functional complementation with patient variant transcripts was conducted to systematically assess protein functionality as a readout for pathogenicity.

resultsA cohort of 14 individuals from 12 unrelated families exhibited highly variable clinical phenotypes, with the majority of them presenting at least one additional variant, potentially accounting for a blended phenotype and complicating phenotypic understanding. We also uncovered extreme clinical heterogeneity and high allele frequencies, occasionally incompatible with a fully penetrant recessive disorder. Human cDNA of previously described and new variants were tested in an ogdhl zebrafish knockout model, adding functional evidence for variant reclassification. We disclosed evidence of hypomorphic alleles as well as a loss-of-function variant without deleterious effects in zebrafish variant testing also showing discordant familial segregation, challenging the relationship of OGDHL as a conventional Mendelian gene. Going further, we uncovered evidence for a complex compensatory relationship among OGDH, OGDHL, and DHTKD1 isoenzymes that are associated with neurodevelopmental disorders and exhibit complex transcriptional compensation patterns with partial functional redundancy.

conclusionsBased on the results of genetic, clinical, and functional studies, we formed three hypotheses in which to frame observations: biallelic OGDHL variants lead to a highly variable monogenic disorder, variants in OGDHL are following a complex pattern of inheritance, or they may not be causative at all. Our study further highlights the continuing challenges of assessing the validity of reported disease-gene associations and effects of variants identified in these genes. This is particularly more complicated in making genetic diagnoses based on identification of variants in genes presenting a highly heterogenous phenotype such as "OGDHL-related disorders".

Indexed as

ProteinsZebrafishAnimalsGene FrequencyHumansKetoglutarate Dehydrogenase ComplexPhenotypeDHTKD1 protein, humanKetoglutarate Dehydrogenase ComplexOGDHL protein, humanProteins2-oxo acid dehydrogenaseDisease modelGenetic compensationMitochondriaNeurodevelopmental disordersOGDHLVariant testingZebrafish

Identifiers

PMID38031187
PMCPMC10688095
OpenAlexW4389137487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.